$VRTX
Market closedVertex Pharmaceuticals Incorpor · NasdaqGS
$529.69
▲ $8.66 (1.66%)
Open
$514.45
Prev close
$521.03
Day range
$513.37 – $534.94
Volume
1.24M
Avg volume
1.16M
Market cap
$134.26B
P/E (TTM)
30.23
Forward P/E
25.94
EPS (TTM)
17.52
52wk change
+26.96%
1M performance
+0.38%$527.67 → $529.69
Latest news
Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack.
Barrons.com · 14h ago
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks · 15h ago
Ahead of Vertex (VRTX) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Zacks · 16h ago
What Would Slower New Drug Sales Do To Vertex Stock?
Trefis · 16h ago
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock
Zacks · 16h ago
What iShares Biotechnology ETF (IBB) Bought: Gilead Leads on Monday
GuruFocus.com · 17h ago
What moved $VRTX before
Logged catalysts for this stock, with the price reaction measured from real closes.
| Date | Factor | What happened | Next day | 1 week | 1 month | vs S&P |
|---|---|---|---|---|---|---|
| Dec 8, 2023 | 💊 FDA approval or rejection | Casgevy approved — the first CRISPR-based therapy cleared in the US Approval was widely expected, so the reaction was muted. | -1.07% | +14.87% | +18.95% | -1.50% |
Predictions on $VRTX
Make a call →Discussions on $VRTX
Start one →Market data from Yahoo Finance. Prices may be delayed. Not financial advice.